Results 151 to 160 of about 74,509 (297)
Glycaemic responses to metformin monotherapy by SNP clusters in patients with type 2 diabetes
Abstract Aims This study retrospectively investigates the association between polygenic risk scores (PRS) derived from SNP clusters and glycaemic response to metformin in patients with newly diagnosed T2D. Materials and Methods Utilizing a dataset from the Taiwan Precision Medicine Initiative, we evaluated alterations in fasting glucose (FBG) and ...
Wayne Huey‐Herng Sheu+10 more
wiley +1 more source
Review on application and development of pharmacogenomics of adverse drug reactions
Adverse drug reactions (ADRs) are a significant public health issue, contributing substantially to patient morbidity and mortality. The growing accessibility of genomic technologies has greatly advanced our understanding of the genetics underlying ADRs ...
Hongyu Bi+6 more
doaj +1 more source
Pharmacogenomics: The promise of personalized medicine
Laviero Mancinelli+2 more
openalex +2 more sources
Pharmacogenetics, pharmacogenomics and airway disease [PDF]
Ian P. Hall
openalex +1 more source
Breaking the paradigm: Dr Insight empowers signature-free, enhanced drug repurposing [PDF]
Motivation: Transcriptome-based computational drug repurposing has attracted considerable interest by bringing about faster and more cost-effective drug discovery.
Baldwin, Nicole E.+4 more
core +1 more source
Skin‐Derived PGD2 Promotes Antigen‐Specific IgE Production via CRTH2 Signaling
Allergy, EarlyView.
Misato Kida+5 more
wiley +1 more source
Abstract Objective Current preclinical epilepsy drug screening relies on animal models that poorly reflect human neurophysiology, leading to high failure rates in clinical translation. We aimed to establish a human in vitro model using human‐induced pluripotent stem cell (hiPSC)–derived cortical neurons cultured on multielectrode arrays (MEAs), capable
Joshua Nicholls+13 more
wiley +1 more source
Molecular Testing in Sickle Cell Disease: From Newborn Screening to Transfusion Care
ABSTRACT Sickle cell disease (SCD) is one of the most frequent monogenic diseases worldwide and a highly heterogeneous and complex disease. SCD care carries several challenges. This includes early and accurate diagnosis as well as optimal red blood cell transfusion matching in this population carrying a high risk of alloimmunization.
Thomas Pincez, Yves D. Pastore
wiley +1 more source
Background Community pharmacists must be well-equipped to advance pharmacogenomics services. Nevertheless, limited data is available regarding pharmacists' knowledge and attitudes toward pharmacogenomics testing.
Azza Ramadan+2 more
doaj +1 more source
Assessing the cost-effectiveness of pharmacogenomics
David L. Veenstra+2 more
openalex +2 more sources